Dr. Robert Whitfield explains that new swelling, pain, or fluid collections more than a year after breast implant surgery need medical evaluation. If fluid is drained, it must be tested for CD30 to reach a diagnosis. The FDA does not recommend removing implants in patients without symptoms.
If you have implants, here is the critical point. New late swelling, a mass, pain, or rash, or a large fluid collection more than a year after surgery deserves evaluation. If fluid is sampled, CD30 testing matters. An untested tap should not close the question. If you have no symptoms, the FDA does not recommend removing implants because of a concern for cancer. Join me Thursday at 6 PM Central. Educational only. Individual care belongs with you and your healthcare provider.
